Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol, United Kingdom | Synapse
December 12, 2022Open Access
Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol, United Kingdom
Key Points
Key points are not available for this paper at this time.
Abstract
AvonCAP is an investigator-led project funded under a collaborative agreement by Pfizer.